211 related articles for article (PubMed ID: 20196837)
1. Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis.
Jin F; Qu LS; Shen XZ
J Exp Clin Cancer Res; 2010 Mar; 29(1):18. PubMed ID: 20196837
[TBL] [Abstract][Full Text] [Related]
2. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F
Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.
Cukjati M; Vaupotic T; Rupreht R; Curin-Serbec V
BMC Med Genet; 2007 Nov; 8():69. PubMed ID: 18036208
[TBL] [Abstract][Full Text] [Related]
7. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
9. [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].
Ropero P; Briceño O; López-Alonso G; Agúndez JA; González Fernández FA; García-Hoz F; Villegas Martínez A; Díaz-Rubio M; Ladero JM
Rev Esp Enferm Dig; 2007 Jul; 99(7):376-81. PubMed ID: 17973580
[TBL] [Abstract][Full Text] [Related]
10. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
[TBL] [Abstract][Full Text] [Related]
11. HFE gene mutations an Apulian population: allele frequencies.
Pietrapertosa A; Vitucci A; Campanale D; Palma A; Renni R; Delios G; Tannoia N
Eur J Epidemiol; 2003; 18(7):685-9. PubMed ID: 12952143
[TBL] [Abstract][Full Text] [Related]
12. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
14. Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin.
Campo S; Restuccia T; Villari D; Raffa G; Cucinotta D; Squadrito G; Pollicino T; Raimondo G
Liver; 2001 Aug; 21(4):233-6. PubMed ID: 11454185
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of the Association between H63D and C282Y Polymorphisms in HFE and Cancer Risk.
Zhang M; Xiong H; Fang L; Lu W; Wu X; Wang YQ; Cai ZM; Wu S
Asian Pac J Cancer Prev; 2015; 16(11):4633-9. PubMed ID: 26107216
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies.
Li M; Wang L; Wang W; Qi XL; Tang ZY
Braz J Med Biol Res; 2014 Feb; 47(3):215-22. PubMed ID: 24604426
[TBL] [Abstract][Full Text] [Related]
17. The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.
Xia J; Xu H; Jiang H; Xie J
Neurosci Lett; 2015 May; 595():99-103. PubMed ID: 25863172
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of HFE gene mutations in Croatian patients suspected of having hereditary hemochromatosis.
Milić S; Ristić S; Starčević-Čizmarević N; Brajenović-Milić B; Crnić-Martinović M; Kapović M; Peterlin B; Štimac D
Med Sci Monit; 2011 Oct; 17(10):CR552-6. PubMed ID: 21959608
[TBL] [Abstract][Full Text] [Related]
19. [Mutations in the HFE gene (C282Y, H63D, S65C) in alcoholic patients with finding of iron overload].
Campos Franco J; González Quintela A; Fernández de Trocóniz LL; Barros Angueira F; Pérez-Quintela BV; Pérez Becerra E; Martínez de Rituerto ST; Otero Antón E; Torre Carballada JA
Rev Clin Esp; 2002 Oct; 202(10):534-9. PubMed ID: 12361551
[TBL] [Abstract][Full Text] [Related]
20. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.
de Diego C; Murga MJ; Martínez-Castro P
Genet Test; 2004; 8(3):263-7. PubMed ID: 15727249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
